WP
CRBU icon

Woodline Partners’s Caribou Biosciences CRBU Stock Holding History

Woodline Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-122,833
Closed -$155K – 914
2025
Q2 		$155K Buy
122,833
+698
+0.6% +$686 ﹤0.01% 906
2025
Q1 		$112K Hold
122,135
– – ﹤0.01% 887
2024
Q4 		$194K Hold
122,135
– – ﹤0.01% 907
2024
Q3 		$239K Sell
122,135
-113,296
-48% -$232K ﹤0.01% 564
2024
Q2 		$386K Sell
235,431
-1,846
-0.8% -$5.9K ﹤0.01% 507
2024
Q1 		$1.22M Sell
237,277
-903,394
-79% -$5.57M 0.01% 451
2023
Q4 		$6.54M Buy
1,140,671
+679,133
+147% +$3.36M 0.07% 282
2023
Q3 		$2.21M Buy
+461,538
New +$2.86M 0.03% 389
2022
Q3 		– Sell
-68,802
Closed -$374K – 768
2022
Q2 		$374K Hold
68,802
– – 0.01% 588
2022
Q1 		$632K Hold
68,802
– – 0.01% 508
2021
Q4 		$1.04M Sell
68,802
-50,471
-42% -$982K 0.01% 500
2021
Q3 		$2.85M Buy
+119,273
New +$2.92M 0.05% 355

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Woodline Partners's CRBU Position: Q3 2025 in Review

Woodline Partners sold out of Caribou Biosciences (CRBU) in Q3 2025, closing a stake of 122,833 shares — an estimated $155K sold.

Woodline Partners first reported a position in CRBU in Q3 2021 and held it in 12 quarters. The position peaked at $6.54M in Q4 2023. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

  • Woodline Partners reported no remaining Caribou Biosciences position as of Q3 2025 after selling out during the quarter.
  • Woodline Partners sold 122,833 Caribou Biosciences shares in Q3 2025, an estimated $155K.
  • Woodline Partners first reported a position in Caribou Biosciences in Q3 2021 and held it in 12 quarters.
  • Woodline Partners's Caribou Biosciences position peaked at $6.54M in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.